Jomed To Begin Anastomosis Device Clinicals In Second Quarter 2000
This article was originally published in The Gray Sheet
Executive Summary
Swedish-based stent manufacturer Jomed is looking to start European clinical studies for a sutureless graft connector anastomosis system by the second quarter of 2000, the company said, in the wake of promising six-month animal data.
You may also be interested in...
Guidant's CTS Buy Provides Platform For Growth In Cardiac Surgery Market
Guidant's planned acquisition of minimally invasive cardiac surgery device maker CardioThoracic Systems for $313 mil. in stock provides greater access to cardiac surgeons as well as a platform for growth in the cardiac surgery market.
AAM Welcomes Proposal To Update Medicare Part D
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s Wants To Break Into Top Five In India
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: